Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results
Pedro Santos-Moreno,1 Paola Castillo,2 Laura Villareal,3 Carlos Pineda,4 Hugo Sandoval,5 Omaira Valencia2 1Scientific Direction, Biomab Center for Rheumatoid Arthritis, Bogotá, D.C., Colombia; 2Research Department, Biomab Center for Rheumatoid Arthritis, Bogotá, D.C., Colombia;...
Guardado en:
Autores principales: | Santos-Moreno P, Castillo P, Villareal L, Pineda C, Sandoval H, Valencia O |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/08d06c424a0f45dfab111ad9edc9f3ff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis
por: Bertoldi I, et al.
Publicado: (2021) -
Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
por: Ríos C, et al.
Publicado: (2017) -
The onset of rheumatoid arthritis following trauma
por: Brawer AE, et al.
Publicado: (2016) -
Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
por: Mysler E, et al.
Publicado: (2021) -
Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
por: Almalag H, et al.
Publicado: (2020)